[Cytokines as immunotherapy in cancer]. 1992

G P van der Schelling, and J N Ijzermans, and R L Marquet, and J Jeekel
Academisch Ziekenhuis Rotterdam-Dijkzigt, afd. Algemene Heelkunde.

UI MeSH Term Description Entries
D007167 Immunotherapy Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection. Immunotherapies
D007372 Interferons Proteins secreted by vertebrate cells in response to a wide variety of inducers. They confer resistance against many different viruses, inhibit proliferation of normal and malignant cells, impede multiplication of intracellular parasites, enhance macrophage and granulocyte phagocytosis, augment natural killer cell activity, and show several other immunomodulatory functions. Interferon
D007378 Interleukins Soluble factors which stimulate growth-related activities of leukocytes as well as other cell types. They enhance cell proliferation and differentiation, DNA synthesis, secretion of other biologically active molecules and responses to immune and inflammatory stimuli. Interleukin
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha
D016207 Cytokines Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner. Cytokine

Related Publications

G P van der Schelling, and J N Ijzermans, and R L Marquet, and J Jeekel
May 1992, Nederlands tijdschrift voor geneeskunde,
G P van der Schelling, and J N Ijzermans, and R L Marquet, and J Jeekel
December 2018, Cold Spring Harbor perspectives in biology,
G P van der Schelling, and J N Ijzermans, and R L Marquet, and J Jeekel
October 2011, Cancers,
G P van der Schelling, and J N Ijzermans, and R L Marquet, and J Jeekel
February 1990, Cancer,
G P van der Schelling, and J N Ijzermans, and R L Marquet, and J Jeekel
January 2019, British journal of cancer,
G P van der Schelling, and J N Ijzermans, and R L Marquet, and J Jeekel
May 2000, Immunological investigations,
G P van der Schelling, and J N Ijzermans, and R L Marquet, and J Jeekel
December 2004, Immunological reviews,
G P van der Schelling, and J N Ijzermans, and R L Marquet, and J Jeekel
January 2000, Immunologic research,
G P van der Schelling, and J N Ijzermans, and R L Marquet, and J Jeekel
January 2021, Drug design, development and therapy,
G P van der Schelling, and J N Ijzermans, and R L Marquet, and J Jeekel
April 2021, Antibody therapeutics,
Copied contents to your clipboard!